2nd Quarter - Report
DLA PIPER LLP (US) for AIMMUNE THERAPEUTICS, INC.
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax issues associated with COVID-19 relief, including the research and development tax credit. H.R. 6713/S. 3593, Furthering Our Recovery With American Research & Development (FORWARD) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA GIERACH | — |
| EVAN M MIGDAIL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.